Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2023 08:45 ET | Source: GRI Bio, Inc.

GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio

- U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic pulmonary fibrosis (IPF) - Company building a robust global patent estate LA JOLLA, CA, June...